secwatch.observer — SEC 8-K summary
======================================

Issuer:     Privia Health Group, Inc. (PRVA)
CIK:        0001759655
Form:       8-K
Filed at:   2022-07-01T23:59:59+00:00
Accession:  0001759655-22-000083
Event type: earnings
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Privia Health reaffirms FY2022 adjusted EBITDA guidance of $52M-$56M
--------------------------------------------------------------------

- Reiterates full-year 2022 adjusted EBITDA range of $52M-$56M, representing 25.6%-35.3% growth over prior year.
- Expects approximately 90% of adjusted EBITDA to convert to free cash flow.
- No reconciliation provided for non-GAAP forward-looking measures; GAAP equivalents not forecastable without unreasonable effort.
- Guidance subject to risks outlined in annual report and other SEC filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759655/000175965522000083/0001759655-22-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759655/000175965522000083/prva-20220701.htm
  HTML page:      https://secwatch.observer/filing/0001759655-22-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer